| View |
DRP-6742-02_PI_01.pdf
|
DRP-6742-02
|
Telmisartan
|
Mizar
|
80 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Hizon Laboratories, Inc.
|
Philippines
|
Renewal
|
20 October 2024
|
23 March 2030
|
| View |
|
DRP-8171-01
|
Vitamin B1 + B6 + B12
|
Fermaflex
|
100 mg/5 mg/50 mcg
|
Tablet
|
-
|
Philmed Labortories, Inc
|
Philippines
|
CLIDP Conversion
|
24 October 2022
|
25 June 2027
|
| View |
|
DRP-8317-02
|
Docetaxel
|
Ocetax
|
80 mg/4 mL
|
Concentrate Solution for IV Infusion
|
Antineoplastic (Taxane)
|
Intas Pharmaceuticals Limited
|
India
|
Renewal
|
20 October 2024
|
19 October 2029
|
| View |
DRP-8402-01_PI_01.pdf
|
DRP-8402-01
|
Allopurinol
|
Alorex
|
300 mg
|
Tablet
|
Antigout
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Renewal
|
05 August 2023
|
20 September 2028
|
| View |
|
DRP-8747-02
|
Omeprazole (as sodium)
|
Omeraz
|
40 mg
|
Lyophilized Powder for Injection (I.V.)
|
-
|
Reyoung Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
24 October 2022
|
21 February 2025
|
| View |
|
DRP-8924-01
|
Metronidazole + Miconazole nitrate
|
Metricored
|
500 mg/100 mg
|
Vaginal Suppository
|
-
|
Farmaprim S.R.L.
|
Republic of Moldova
|
CLIDP Conversion
|
24 October 2022
|
24 June 2025
|
| View |
|
DRP-9115-02
|
Dexamethasone + Tobramycin
|
Aguadexa
|
1 mg / 3 mg per mL (0.1% / 0.3% w/v)
|
|
-
|
Alwin DMD Pharmaceuticals
|
India
|
CLIDP Conversion
|
24 October 2022
|
10 September 2025
|
| View |
|
DRP-10275-06
|
Febuxostat
|
Quric 40
|
40 mg
|
Film-Coated Tablet
|
-
|
Titan Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 October 2022
|
06 September 2026
|
| View |
|
DRP-10372-01
|
Colchicine
|
Acugout
|
500 mcg
|
Tablet
|
-
|
Flamingo Pharmaceuticals Ltd
|
India
|
CLIDP Conversion
|
24 October 2022
|
26 November 2027
|
| View |
|
DRP-10399-01
|
Amoxicillin (as trihydrate)
|
None
|
500 mg
|
Capsule
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
24 October 2022
|
06 August 2025
|
| View |
|
DRP-10545-01
|
Cefalexin
|
Xelares
|
500 mg
|
Capsule
|
-
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
24 October 2022
|
18 May 2025
|
| View |
|
DRP-10631-03
|
Vancomycin (as hydrochloride)
|
Vanclaire
|
1 g
|
Powder for Injection (IV)
|
-
|
Venus Remedies, Limited
|
India
|
CLIDP Conversion
|
24 October 2022
|
10 November 2026
|
| View |
|
DRP-10697-01
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Lintaz
|
4 g/ 500 mg
|
Powder for Injection for IV Infusion
|
-
|
Kilitch Drugs (India) Ltd.
|
India
|
CLIDP Conversion
|
24 October 2022
|
10 November 2026
|
| View |
|
DRP-10890-04
|
Cefepime (as hydrochloride) + Sulbactam (as sodium)
|
Gocifime
|
1.5 g
|
Powder for Injection (I.M./I.V)
|
-
|
Swiss Parenterals Ltd.
|
India
|
CLIDP Conversion
|
24 October 2022
|
14 December 2026
|
| View |
|
DRP-11119-01
|
Palonosetron (as hydrochloride)
|
X-Noseia
|
50 mcg/mL (250 mcg/5 mL)
|
Solution for Intravenous Injection
|
-
|
USV Private Limited
|
India
|
CLIDP Conversion
|
24 October 2022
|
04 February 2027
|
| View |
|
DRP-11330-01
|
Rosuvastatin (as calcium)
|
Varostin
|
10 mg
|
Film-Coated Tablet
|
-
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 October 2022
|
03 March 2027
|
| View |
|
DRP-11772-01
|
Levocetirizine hydrochloride
|
Levocemax
|
5 mg
|
Tablet
|
-
|
Simpex Pharma Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 October 2022
|
27 April 2027
|
| View |
|
DRP-12057-01
|
Losartan Potassium
|
Baczartan
|
50 mg
|
Film-Coated Tablet
|
-
|
Mankind Pharma Limited (Unit II)
|
India
|
CLIDP Conversion
|
24 October 2022
|
03 June 2027
|
| View |
|
DRP-12144-01
|
Amlodipine (as besilate)
|
Odasyl
|
5mg
|
Tablet
|
-
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
24 October 2022
|
03 December 2026
|
| View |
|
DRP-12215-02
|
Acetylcysteine
|
Acyden
|
600 mg
|
Effervescent Tablet
|
-
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
24 October 2022
|
01 July 2027
|